Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 37 Liver Neoplasms 18 Neoplasm Metastasis 17 Colorectal Neoplasms 13 Cholangiocarcinoma 11 Pancreatic Neoplasms 9 Lung Neoplasms 8 Colonic Neoplasms 8 Breast Neoplasms 8 Barrett Esophagus 7 Recurrence 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Thyroid Neoplasms 5 Rectal Neoplasms 5 Thyroid Nodule 4 Pain 4 Neoplasms 4 Kidney Neoplasms 4 Esophageal Neoplasms 4 Thyroid Cancer, Papillary 3 Biliary Tract Neoplasms 3 Agnosia 3 Thyroid Diseases 2 Prostatic Neoplasms 2 Leiomyoma 2 Hyperaldosteronism 2 Cancer Pain 2 Bile Duct Neoplasms 2 Uterine Cervical Neoplasms 1

Interventions

Sorafenib 2 nimotuzumab 1 lenvatinib 1 atezolizumab 1 Tirapazamine 1 Radiotherapy 1 Radiosurgery 1 Radiofrequency Ablation 1 Immune Checkpoint Inhibitors 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × HCC × Radiofrequency Ablation × Clear all

NCT01470495 2017-03-28

REPEAT

Southwest Hospital, China

Phase NA Unknown

HCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡